Long-Term Outcomes of the PRESERFLO MicroShunt Implant in a Heterogeneous Glaucoma Cohort

The Preserflo MicroShunt represents a novel glaucoma treatment device, necessitating long-term follow-up data to accurately assess its efficacy. The aim of this study is to report real-world data of a heterogenous glaucoma cohort who received Preserflo implantation at a specialized glaucoma clinic....

Descripción completa

Detalles Bibliográficos
Autores principales: Storp, Jens Julian, Vietmeier, Friederike Elisabeth, Merté, Ralph-Laurent, Koch, Raphael, Zimmermann, Julian Alexander, Eter, Nicole, Brücher, Viktoria Constanze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342323/
https://www.ncbi.nlm.nih.gov/pubmed/37445509
http://dx.doi.org/10.3390/jcm12134474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342323/
https://www.ncbi.nlm.nih.gov/pubmed/37445509
http://dx.doi.org/10.3390/jcm12134474

Ejemplares similares